A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada
Clinical trial NCT05424562 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05424562
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-07
- Primary completion
- 2027-03-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.